Suppr超能文献

用于肿瘤PET/CT成像的氟-18标记氨基酸

Fluorine-18 labeled amino acids for tumor PET/CT imaging.

作者信息

Qi Yiqiang, Liu Xiaohui, Li Jun, Yao Huiqian, Yuan Shuanghu

机构信息

School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital affiliated to Shandong University, Jinan, Shandong, China.

出版信息

Oncotarget. 2017 Aug 4;8(36):60581-60588. doi: 10.18632/oncotarget.19943. eCollection 2017 Sep 1.

Abstract

Tumor glucose metabolism and amino acid metabolism are usually enhanced, F-FDG for tumor glucose metabolism PET imaging has been clinically well known, but tumor amino acid metabolism PET imaging is not clinically familiar. Radiolabeled amino acids (AAs) are an important class of PET/CT tracers that target the upregulated amino acid transporters to show elevated amino acid metabolism in tumor cells. Radiolabeled amino acids were observed to have high uptake in tumor cells but low in normal tissues and inflammatory tissues. The radionuclides used in labeling amino acids include O, N, C, I, F and Ga, among which the most commonly used is F [1]. Available data support the use of certain F-labeled AAs for PET/CT imaging of gliomas, neuroendocrine tumors, prostate cancer and breast cancer [2, 3]. With the progress of the method of F labeling AAs [4-6], F-labeled AAs are well established for tumor PET/CT imaging. This review focuses on the current status of key clinical applications of 18F-labeled AAs in tumor PET/CT imaging.

摘要

肿瘤葡萄糖代谢和氨基酸代谢通常会增强,18F-FDG用于肿瘤葡萄糖代谢的PET成像在临床上已广为人知,但肿瘤氨基酸代谢的PET成像在临床上并不常见。放射性标记氨基酸(AAs)是一类重要的PET/CT示踪剂,其靶向上调的氨基酸转运体以显示肿瘤细胞中升高的氨基酸代谢。观察到放射性标记氨基酸在肿瘤细胞中摄取高,但在正常组织和炎症组织中摄取低。用于标记氨基酸的放射性核素包括O、N、C、I、F和Ga,其中最常用的是F[1]。现有数据支持使用某些F标记的氨基酸进行胶质瘤、神经内分泌肿瘤、前列腺癌和乳腺癌的PET/CT成像[2,3]。随着F标记氨基酸方法的进展[4-6],F标记氨基酸在肿瘤PET/CT成像中已得到充分确立。本综述重点关注18F标记氨基酸在肿瘤PET/CT成像关键临床应用的现状。

相似文献

1
Fluorine-18 labeled amino acids for tumor PET/CT imaging.
Oncotarget. 2017 Aug 4;8(36):60581-60588. doi: 10.18632/oncotarget.19943. eCollection 2017 Sep 1.
2
Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.
Front Chem. 2018 Jan 15;5:124. doi: 10.3389/fchem.2017.00124. eCollection 2017.
7
Fluorine-18 labeled amino acids for oncologic imaging with positron emission tomography.
Curr Top Med Chem. 2013;13(8):871-91. doi: 10.2174/1568026611313080002.
8
Radiolabeled amino acids for oncologic imaging.
J Nucl Med. 2013 Jul;54(7):1007-10. doi: 10.2967/jnumed.112.113100. Epub 2013 May 24.
10
(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Radiology. 2014 Nov;273(2):549-59. doi: 10.1148/radiol.14140028. Epub 2014 Jul 16.

引用本文的文献

1
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [F]FDG Alternatives.
Mol Diagn Ther. 2025 Jan;29(1):55-66. doi: 10.1007/s40291-024-00756-4. Epub 2024 Nov 8.
3
Asymmetric synthesis of unnatural α-amino acids through photoredox-mediated C-O bond activation of aliphatic alcohols.
Chem Sci. 2024 Apr 17;15(19):7316-7323. doi: 10.1039/d4sc00403e. eCollection 2024 May 15.
4
The regulation of amino acid metabolism in tumor cell death: from the perspective of physiological functions.
Apoptosis. 2023 Oct;28(9-10):1304-1314. doi: 10.1007/s10495-023-01875-9. Epub 2023 Jul 31.
5
An overview of radiolabeled amino acid tracers in oncologic imaging.
Front Oncol. 2023 Feb 17;13:983023. doi: 10.3389/fonc.2023.983023. eCollection 2023.
6
Oxidative stress in multiple sclerosis-Emerging imaging techniques.
Front Neurol. 2023 Jan 12;13:1025659. doi: 10.3389/fneur.2022.1025659. eCollection 2022.
7
Radiosynthesis and Analysis of (S)-4-(3-[F]Fluoropropyl)-L-Glutamic Acid.
Mol Imaging Biol. 2023 Jun;25(3):586-595. doi: 10.1007/s11307-022-01793-3. Epub 2022 Dec 16.
9
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.
Int J Mol Sci. 2022 Apr 30;23(9):5023. doi: 10.3390/ijms23095023.
10
Arene radiofluorination enabled by photoredox-mediated halide interconversion.
Nat Chem. 2022 Feb;14(2):216-223. doi: 10.1038/s41557-021-00835-7. Epub 2021 Dec 13.

本文引用的文献

1
Dose Mapping After Endoradiotherapy with Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days.
J Nucl Med. 2018 Jan;59(1):75-81. doi: 10.2967/jnumed.117.193706. Epub 2017 Jun 6.
4
IDH mutation is paradoxically associated with higher F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1306-1311. doi: 10.1007/s00259-017-3668-6. Epub 2017 Mar 14.
6
Metabolic Imaging of Glutamine in Cancer.
J Nucl Med. 2017 Apr;58(4):533-537. doi: 10.2967/jnumed.116.182345. Epub 2017 Feb 23.
7
[F](2,4)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition.
Cancer Res. 2017 Mar 15;77(6):1476-1484. doi: 10.1158/0008-5472.CAN-16-1945. Epub 2017 Feb 15.
8
Head-to-head comparison between F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):979-987. doi: 10.1007/s00259-016-3605-0. Epub 2017 Jan 3.
10
F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L.
Eur J Nucl Med Mol Imaging. 2017 May;44(5):812-821. doi: 10.1007/s00259-016-3586-z. Epub 2016 Nov 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验